Bloodstream Infection Testing Market - Top Companies and Manufacturers

Companies Dominating the Bloodstream Infection Testing Landscape

The major players in the bloodstream infection testing market are offering a detailed portfolio of blood test-related products. These companies introduced advanced technologies that enable detailed visualization of blood test procedures.

Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

biomerieux SA
Bruker Corporation
Danaher Corporation
DiaSorin S.p.A
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
T2 Biosystems, Inc.
Accelerate Diagnostics, Inc.
F. Hoffmann-La Roche Ltd

Browse Key Market Insights with Data Illustration:

Bloodstream Infection Testing Market Size, Growth Trends 2037

In the News

Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System) which is a breakthrough innovation for people who are suffering from chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The System is designed in such a way as to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.

Danaher Corporation launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild traumatic brain injury (TBI). Under this program, researchers at Johns Hopkins University will leverage technology from Beckman Coulter Diagnostics which is a Danaher subsidiary and leader in clinical diagnostics, to potentially establish correlations between a new biomarker panel and clinical outcomes.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of bloodstream infection testing is assessed at USD 777.93 million.

The bloodstream infection testing market size was over USD 749.74 million in 2024 and is projected to reach USD 1.36 billion by 2037, witnessing around 4.7% CAGR during the forecast period i.e., between 2025-2037. The growing frequency of infectious diseases will propel the market growth.

North America industry is poised to account for largest revenue share of 34% by 2037, influenced by rapid growth in the geriatric population with a large number of healthcare facilities available in the region in the region.

The major players in the market include Abbott Laboratories, biomerieux SA, Bruker Corporation, Danaher Corporation, DiaSorin S.p.A, Siemens Healthineers AG, Thermo Fisher Scientific Inc., T2 Biosystems, Inc., Accelerate Diagnostics, Inc., F. Hoffmann-La Roche Ltd

Bloodstream Infection Testing Market - Top Companies and Manufacturers

Companies Dominating the Bloodstream Infection Testing Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the bloodstream infection testing market worth?

Why is the demand for bloodstream infection testing growing?

Which region dominated the majority of bloodstream infection testing industry share?

Who are the top bloodstream infection testing companies?